4,807
Views
6
CrossRef citations to date
0
Altmetric
Review

Coenzyme Q10 in COPD: An Unexplored Opportunity?

ORCID Icon, ORCID Icon, & ORCID Icon
Pages 114-122 | Received 15 Jul 2020, Accepted 06 Nov 2020, Published online: 13 Jan 2021

References

  • Vogelmeier CF, Criner GJ, Martinez FJ, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report: GOLD executive summary. Arch Bronconeumol. 2017;53(3):128–149. DOI:10.1016/j.arbres.2017.02.001
  • GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5(9):691–706.
  • Corlateanu A, Covantev S, Mathioudakis AG, et al. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease. Respir Investig. 2016;54(6):387–396. DOI:10.1016/j.resinv.2016.07.001
  • Fischer BM, Pavlisko E, Voynow JA. Pathogenic triad in COPD: oxidative stress, protease-antiprotease imbalance, and inflammation. Int J Chron Obstruct Pulmon Dis. 2011;6:413–421. DOI:10.2147/COPD.S10770
  • Garrido-Maraver J, Cordero MD, Oropesa-Avila M, et al. Coenzyme q10 therapy. Mol Syndromol. 2014;5(3–4):187–197. DOI:10.1159/000360101
  • Wiegman CH, Michaeloudes C, Haji G, COPDMAP, et al. Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2015;136(3):769–780. DOI:10.1016/j.jaci.2015.01.046
  • Zozina VI, Covantev S, Goroshko OA, et al. Coenzyme Q10 in cardiovascular and metabolic diseases: current state of the problem. Curr Cardiol Rev. 2018.
  • Gokce M, Saydam O, Hanci V, et al. Antioxidant vitamins C, E and coenzyme Q10 vs dexamethasone: comparisons of their effects in pulmonary contusion model. J Cardiothorac Surg. 2012;7:92. DOI:10.1186/1749-8090-7-92
  • Fang T, Wang M, Xiao H, et al. Mitochondrial dysfunction and chronic lung disease. Cell Biol Toxicol. 2019;35(6):493–502. DOI:10.1007/s10565-019-09473-9
  • Schaberg T, Klein U, Rau M, et al. Subpopulations of alveolar macrophages in smokers and nonsmokers: relation to the expression of CD11/CD18 molecules and superoxide anion production. Am J Respir Crit Care Med. 1995;151(5):1551–1558. DOI:10.1164/ajrccm.151.5.7735614
  • Kirkham PA, Barnes PJ. Oxidative stress in COPD. Chest. 2013;144(1):266–273. DOI:10.1378/chest.12-2664
  • Vézina F-A, Cantin AM. Antioxidants and chronic obstructive pulmonary disease. Chronic Obstr Pulm Dis. 2018;5(4):277–288. DOI:10.15326/jcopdf.5.4.2018.0133
  • Couillard A, Prefaut C. From muscle disuse to myopathy in COPD: potential contribution of oxidative stress. Eur Respir J. 2005;26(4):703–719. DOI:10.1183/09031936.05.00139904
  • Couillard A, Maltais F, Saey D, et al. Exercise-induced quadriceps oxidative stress and peripheral muscle dysfunction in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167(12):1664–1669. DOI:10.1164/rccm.200209-1028OC
  • Rahman I, van Schadewijk AA, Crowther AJ, et al. 4-Hydroxy-2-nonenal, a specific lipid peroxidation product, is elevated in lungs of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(4):490–495. DOI:10.1164/rccm.2110101
  • Drost EM, Skwarski KM, Sauleda J, et al. Oxidative stress and airway inflammation in severe exacerbations of COPD. Thorax. 2005;60(4):293–300. DOI:10.1136/thx.2004.027946
  • Kodgule R, Salvi S. Exposure to biomass smoke as a cause for airway disease in women and children. Curr Opin Allergy Clin Immunol. 2012;12(1):82–90. DOI:10.1097/ACI.0b013e32834ecb65
  • Di Stefano A, Caramori G, Oates T, et al. Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD. Eur Respir J. 2002;20(3):556–563. DOI:10.1183/09031936.02.00272002
  • Rossman MJ, Groot HJ, Reese V, et al. Oxidative stress and COPD: the effect of oral antioxidants on skeletal muscle fatigue. Med Sci Sports Exerc. 2013;45(7):1235–1243. DOI:10.1249/MSS.0b013e3182846d7e
  • Koechlin C, Couillard A, Simar D, et al. Does oxidative stress alter quadriceps endurance in chronic obstructive pulmonary disease? Am J Respir Crit Care Med. 2004;169(9):1022–1027. DOI:10.1164/rccm.200310-1465OC
  • Potgieter M, Pretorius E, Pepper MS. Primary and secondary coenzyme Q10 deficiency: the role of therapeutic supplementation. Nutr Rev. 2013;71(3):180–188. DOI:10.1111/nure.12011
  • Hernandez-Camacho JD, Bernier M, Lopez-Lluch G, et al. Coenzyme Q10 supplementation in aging and disease. Front Physiol. 2018;14(3):164–174.
  • Bentinger M, Tekle M, Dallner G. Coenzyme Q-biosynthesis and functions. Biochem Biophys Res Commun. 2010;396(1):74–79. DOI:10.1016/j.bbrc.2010.02.147
  • Lopez-Lluch G, Rodriguez-Aguilera JC, Santos-Ocana C, et al. Is coenzyme Q a key factor in aging? Mech Ageing Dev. 2010;131(4):225–235.
  • Alcazar-Fabra M, Navas P, Brea-Calvo G. Coenzyme Q biosynthesis and its role in the respiratory chain structure. Biochim Biophys Acta. 2016;1857(8):1073–1078. DOI:10.1016/j.bbabio.2016.03.010
  • Gomez-Diaz C, Rodriguez-Aguilera JC, Barroso MP, et al. Antioxidant ascorbate is stabilized by NADH-coenzyme Q10 reductase in the plasma membrane. J Bioenerg Biomembr. 1997;29(3):251–257. DOI:10.1023/a:1022410127104
  • Thomas SR, Neuzil J, Stocker R. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler Thromb Vasc Biol. 1996;16(5):687–696. DOI:10.1161/01.atv.16.5.687
  • Turunen M, Wehlin L, Sjoberg M, et al. Beta2-Integrin and lipid modifications indicate a non-antioxidant mechanism for the anti-atherogenic effect of dietary coenzyme Q10. Biochem Biophys Res Commun. 2002;296(2):255–260. DOI:10.1016/S0006-291X(02)00871-9
  • Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does alpha-tocopherol. Proc Natl Acad Sci USA. 1991;88(5):1646–1650. DOI:10.1073/pnas.88.5.1646
  • Mashima R, Witting PK, Stocker R. Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol. 2001;12(4):411–418. DOI:10.1097/00041433-200108000-00007
  • Schmelzer C, Lindner I, Vock C, et al. Functional connections and pathways of coenzyme Q10-inducible genes: an in-silico study. IUBMB Life. 2007;59(10):628–633. DOI:10.1080/15216540701545991
  • Corlateanu A, Odajiu I, Botnaru V, et al. From smoking to COPD–current approaches. Pneumologia. 2016;65(1):20–23.
  • Dietrich M, Block G, Norkus EP, et al. Smoking and exposure to environmental tobacco smoke decrease some plasma antioxidants and increase gamma-tocopherol in vivo after adjustment for dietary antioxidant intakes. Am J Clin Nutr. 2003;77(1):160–166. DOI:10.1093/ajcn/77.1.160
  • Niklowitz P, Fischer A, Onur S, et al. Smoking habits and coenzyme Q10 status in healthy European adults. Arch Med Sci. 2016;12(4):715–720. DOI:10.5114/aoms.2016.60953
  • Song SM, Park YS, Lee A, et al. Concentrations of blood vitamin A, C, E, coenzyme Q10 and urine cotinine related to cigarette smoking exposure. Korean J Lab Med. 2009;29(1):10–16. DOI:10.3343/kjlm.2009.29.1.10
  • Al-Bazi MM, Elshal MF, Khoja SM. Reduced coenzyme Q(10) in female smokers and its association with lipid profile in a young healthy adult population. Arch Med Sci. 2011;7(6):948–954. DOI:10.5114/aoms.2011.26605
  • Kaikkonen J, Nyyssonen K, Tuomainen TP, et al. Determinants of plasma coenzyme Q10 in humans. FEBS Lett. 1999;443(2):163–166. DOI:10.1016/S0014-5793(98)01712-8
  • Miles MV, Horn PS, Morrison JA, et al. Plasma coenzyme Q10 reference intervals, but not redox status, are affected by gender and race in self-reported healthy adults. Clin Chim Acta. 2003;332(1–2):123–132. DOI:10.1016/S0009-8981(03)00137-2
  • Kontush A, Reich A, Baum K, et al. Plasma ubiquinol-10 is decreased in patients with hyperlipidaemia. Atherosclerosis. 1997;129(1):119–126. DOI:10.1016/S0021-9150(96)06021-2
  • Hunninghake GW, Crystal RG. Cigarette smoking and lung destruction. Accumulation of neutrophils in the lungs of cigarette smokers. Am Rev Respir Dis. 1983;128(5):833–838. DOI:10.1164/arrd.1983.128.5.833
  • Mateos F, Brock JH, Perez-Arellano JL. Iron metabolism in the lower respiratory tract. Thorax. 1998;53(7):594–600. DOI:10.1136/thx.53.7.594
  • Thompson ABB, Heires A, et al. Lower respiratory tract iron burden is increased in association with cigarette smoking. J Lab Clin Med. 1999;117:494–499.
  • Wesselius LJ, Nelson ME, Skikne BS. Increased release of ferritin and iron by iron-loaded alveolar macrophages in cigarette smokers. Am J Respir Crit Care Med. 1994;150(3):690–695. DOI:10.1164/ajrccm.150.3.8087339
  • MacNee W. Oxidants/antioxidants and COPD. Chest. 2000;117(5 Suppl 1):303S–317S. DOI:10.1378/chest.117.5_suppl_1.303s-a
  • Domej W, Oettl K, Renner W. Oxidative stress and free radicals in COPD-implications and relevance for treatment. Int J Chron Obstruct Pulmon Dis. 2014;9:1207–1224. DOI:10.2147/COPD.S51226
  • Rojewski AM, Baldassarri S, Cooperman NA, Comorbidities Workgroup of the Society for Research on Nicotine and Tobacco (SRNT) Treatment Network, et al. Exploring issues of comorbid conditions in people who smoke. Nicotine Tob Res. 2016;18(8):1684–1696. DOI:10.1093/ntr/ntw016
  • Mantle D, Hargreaves I. Coenzyme Q10 and degenerative disorders affecting longevity: An overview. Antioxidants (Basel, Switzerland). 2019;8(2):44. DOI:10.3390/antiox8020044
  • Hargreaves IP. Coenzyme Q10 as a therapy for mitochondrial disease. Int J Biochem Cell Biol. 2014;49:105–111. DOI:10.1016/j.biocel.2014.01.020
  • Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. DOI:10.1164/rccm.201209-1665OC
  • Sunnetcioglu A, Alp HH, Sertogullar Ndan B, et al. Evaluation of oxidative damage and antioxidant mechanisms in COPD, lung cancer, and obstructive sleep apnea syndrome. Respir Care. 2016;61(2):205–211. DOI:10.4187/respcare.04209
  • Wada H, Hagiwara S, Saitoh E, et al. Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10. Pathophysiology. 2006;13(1):29–33. DOI:10.1016/j.pathophys.2005.09.014
  • Fujimoto S, Kurihara N, Hirata K, et al. Effects of coenzyme Q10 administration on pulmonary function and exercise performance in patients with chronic lung diseases. Clin Investig. 1993;71(8 Suppl):S162–S166. DOI:10.1007/BF00226860
  • Tanrikulu AC, Abakay A, Evliyaoglu O, et al. Coenzyme Q10, copper, zinc, and lipid peroxidation levels in serum of patients with chronic obstructive pulmonary disease. Biol Trace Elem Res. 2011;143(2):659–667. DOI:10.1007/s12011-010-8897-5
  • Mancini A, Corbo GM, Gaballo A, et al. Relationships between plasma CoQ10 levels and thyroid hormones in chronic obstructive pulmonary disease. Biofactors. 2005;25(1–4):201–204. DOI:10.1002/biof.5520250124
  • Gazdik F, Gvozdjakova A, Nadvornikova R, et al. Decreased levels of coenzyme Q(10) in patients with bronchial asthma. Allergy. 2002;57(9):811–814. DOI:10.1034/j.1398-9995.2002.23747.x
  • Gvozdjakova A, Kucharska J, Bartkovjakova M, et al. Coenzyme Q10 supplementation reduces corticosteroids dosage in patients with bronchial asthma. Biofactors. 2005;25(1–4):235–240.
  • Corlateanu A, Covantev S, Mathioudakis AG, et al. Ashtma-Chronic obstructive pulmonary disease overlap syndrome (ACOS): current evidence and future research directions. COPD Res Pract. 2017;3(1):6. DOI:10.1186/s40749-017-0025-x
  • Ishihara Y, Uchida Y, Kitamura S, et al. Effect of coenzyme Q10, a quinone derivative, on guinea pig lung and tracheal tissue. Arzneimittelforschung. 1985;35(6):929–933.
  • Lim HK, Jayaweera S, Calderone A, et al. Protective role of coenzyme Q10 in two models of rat lung injury. ANZ J Surg. 2010;80(4):265–270. DOI:10.1111/j.1445-2197.2009.05085.x
  • Hanagiri T, Igisu H, Shiraishi T, et al. Effects of coenzyme Q10 on lung preservation: a study with an isolated rat lung reperfusion model. J Uoeh. 1994;16(1):85–89. DOI:10.7888/juoeh.16.85
  • Baskaran R, Shanmugam S, Nagayya-Sriraman S, et al. The effect of coenzyme Q10 on the pharmacokinetic parameters of theophylline. Arch Pharm Res. 2008;31(7):938–944. DOI:10.1007/s12272-001-1250-1
  • Carvalho TC, McCook JP, Narain NR, et al. Development of aqueous dispersions of coenzyme Q10 for pulmonary delivery and the dynamics of active vibrating-mesh aerosolization. Int J Pharm. 2016;514(2):407–419. DOI:10.1016/j.ijpharm.2016.10.011
  • Marinari S, Manigrasso MR, De Benedetto F. Effects of nutraceutical diet integration, with coenzyme Q10 (Q-Ter multicomposite) and creatine, on dyspnea, exercise tolerance, and quality of life in COPD patients with chronic respiratory failure. Multidiscip Respir Med. 2013;8(1):40. DOI:10.1186/2049-6958-8-40
  • De Benedetto F, Pastorelli R, Ferrario M, et al. Supplementation with Qter((R)) and Creatine improves functional performance in COPD patients on long term oxygen therapy. Respir Med. 2018;142:86–93. DOI:10.1016/j.rmed.2018.08.002
  • Comhair SAA, Grandon D, Khan A, et al. Coenzyme Q in asthma. Am J Respir Crit Care Med. 2015;191(11):1336–1338. DOI:10.1164/rccm.201412-2259LE
  • Farazi A, Sofian M, Jabbariasl M, et al. Coenzyme Q(10) administration in community-acquired pneumonia in the elderly. Iran Red Crescent Med J. 2014;16(12):e18852. DOI:10.5812/ircmj.18852
  • Kelekci S, Evliyaoglu O, Sen V, et al. The relationships between clinical outcome and the levels of total antioxidant capacity (TAC) and coenzyme Q (CoQ 10) in children with pandemic influenza (H 1 N1) and seasonal flu. Eur Rev Med Pharmacol Sci. 2012;16(8):1033–1038.
  • Dal Negro RW, Bonadiman L, Turco P. Prevalence of different comorbidities in COPD patients by gender and GOLD stage. Multidiscip Respir Med. 2015;10(1):24–24. DOI:10.1186/s40248-015-0023-2
  • Divo M, Cote C, Torres JPd, for the BODE Collaborative Group, et al. Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(2):155–161. DOI:10.1164/rccm.201201-0034OC
  • Alehagen U, Aaseth J, Johansson P. Reduced cardiovascular mortality 10 years after supplementation with selenium and coenzyme Q10 for four years: follow-up results of a prospective randomized double-blind placebo-controlled trial in elderly citizens. PLoS One. 2015;10(12):e0141641. DOI:10.1371/journal.pone.0141641
  • Lee BJ, Tseng YF, Yen CH, et al. Effects of coenzyme Q10 supplementation (300 mg/day) on antioxidation and anti-inflammation in coronary artery disease patients during statins therapy: a randomized, placebo-controlled trial. Nutr J. 2013;12(1):142. DOI:10.1186/1475-2891-12-142
  • Lee BJ, Huang YC, Chen SJ, et al. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Nutrition. 2012;28(3):250–255. DOI:10.1016/j.nut.2011.06.004
  • Lee BJ, Huang YC, Chen SJ, et al. Effects of coenzyme Q10 supplementation on inflammatory markers (high-sensitivity C-reactive protein, interleukin-6, and homocysteine) in patients with coronary artery disease. Nutrition. 2012;28(7–8):767–772. DOI:10.1016/j.nut.2011.11.008
  • Ayers J, Cook J, Koenig RA, et al. Recent developments in the role of coenzyme Q10 for coronary heart disease: a systematic review. Curr Atheroscler Rep. 2018;20(6):29. DOI:10.1007/s11883-018-0730-1
  • Lei L, Liu Y. Efficacy of coenzyme Q10 in patients with cardiac failure: a meta-analysis of clinical trials. BMC Cardiovasc Disord. 2017;17(1):196. DOI:10.1186/s12872-017-0628-9
  • Fischer A, Onur S, Niklowitz P, et al. Coenzyme Q10 status as a determinant of muscular strength in two independent cohorts. PLoS One. 2016;11(12):e0167124. DOI:10.1371/journal.pone.0167124
  • Sahebkar A, Simental-Mendia LE, Stefanutti C, et al. Supplementation with coenzyme Q10 reduces plasma lipoprotein(a) concentrations but not other lipid indices: A systematic review and meta-analysis. Pharmacol Res. 2016;105:198–209. DOI:10.1016/j.phrs.2016.01.030
  • Sharifi N, Tabrizi R, Moosazadeh M, et al. The effects of coenzyme Q10 supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Curr Pharm Des. 2018;24(23):2729–2742. DOI:10.2174/1381612824666180406104516
  • Suksomboon N, Poolsup N, Juanak N. Effects of coenzyme Q10 supplementation on metabolic profile in diabetes: a systematic review and meta-analysis. J Clin Pharm Ther. 2015;40(4):413–418. DOI:10.1111/jcpt.12280
  • Yoo J-Y, Yum K-S. Effect of coenzyme Q(10) on insulin resistance in Korean patients with prediabetes: a pilot single-center, randomized, double-blind, placebo-controlled study. BioMed Res Int. 2018;2018:1613247. DOI:10.1155/2018/1613247
  • Amin MM, Asaad GF, Abdel Salam RM, et al. Novel CoQ10 antidiabetic mechanisms underlie its positive effect: modulation of insulin and adiponectine receptors, Tyrosine kinase, PI3K, glucose transporters, sRAGE and visfatin in insulin resistant/diabetic rats. PLoS One. 2014;9(2):e89169. DOI:10.1371/journal.pone.0089169
  • Eriksson JG, Forsén TJ, Mortensen SA, et al. The effect of coenzyme Q10 administration on metabolic control in patients with type 2 diabetes mellitus. Biofactors. 1999;9(2–4):315–318. DOI:10.1002/biof.5520090229
  • Mehmetoglu I, Yerlikaya FH, Kurban S. Correlation between vitamin A, E, coenzyme Q(10) and degree of insulin resistance in obese and non-obese subjects. J Clin Biochem Nutr. 2011;49(3):159–163. DOI:10.3164/jcbn.11-08
  • Ulla A, Mohamed MK, Sikder B, et al. Coenzyme Q10 prevents oxidative stress and fibrosis in isoprenaline induced cardiac remodeling in aged rats. BMC Pharmacol Toxicol. 2017;18(1):29–29. DOI:10.1186/s40360-017-0136-7
  • Xue R, Wang J, Yang L, et al. Coenzyme Q10 ameliorates pancreatic fibrosis via the ROS-triggered mTOR signaling pathway. Oxid Med Cell Longev. 2019;2019:8039694. DOI:10.1155/2019/8039694
  • Tarry-Adkins JL, Fernandez-Twinn DS, Hargreaves IP, et al. Coenzyme Q10 prevents hepatic fibrosis, inflammation, and oxidative stress in a male rat model of poor maternal nutrition and accelerated postnatal growth. Am J Clin Nutr. 2016;103(2):579–588. DOI:10.3945/ajcn.115.119834
  • Cicero AFG, Colletti A, Bellentani S. Nutraceutical approach to non-alcoholic fatty liver disease (NAFLD): the available clinical evidence. Nutrients. 2018;10(9):1153. DOI:10.3390/nu10091153
  • Farsi F, Mohammadshahi M, Alavinejad P, et al. Functions of coenzyme Q10 supplementation on liver enzymes, markers of systemic inflammation, and adipokines in patients affected by nonalcoholic fatty liver disease: a double-blind, placebo-controlled, randomized clinical trial. J Am Coll Nutr. 2016;35(4):346–353. DOI:10.1080/07315724.2015.1021057
  • Cooney RV, Dai Q, Gao YT, et al. Low plasma coenzyme Q(10) levels and breast cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev. 2011;20(6):1124–1130. DOI:10.1158/1055-9965.EPI-10-1261
  • Burlaka AP, Ganusevich II, Golotiuk VV, et al. Superoxide- and NO-dependent mechanisms of antitumor and antimetastatic effect of L-arginine hydrochloride and coenzyme Q10. Exp Onc. 2016;38(1):31–35. DOI:10.31768/2312-8852.2016.38(1):31-35
  • Tafazoli A. Coenzyme Q10 in breast cancer care. Future Oncol. 2017;13(11):1035–1041. DOI:10.2217/fon-2016-0547
  • Cobanoglu U, Demir H, Cebi A, et al. Lipid peroxidation, DNA damage and coenzyme Q10 in lung cancer patients–markers for risk assessment? Asian Pac J Cancer Prev. 2011;12(6):1399–1403.
  • Hertz N, Lister RE. Improved survival in patients with end-stage cancer treated with coenzyme Q(10) and other antioxidants: a pilot study. J Int Med Res. 2009;37(6):1961–1971. DOI:10.1177/147323000903700634
  • Johansson P, Dahlstrom O, Dahlstrom U, et al. Improved health-related quality of life, and more days out of hospital with supplementation with selenium and coenzyme Q10 combined. Results from a double blind, placebo-controlled prospective study. J Nutr Health Aging. 2015;19(9):870–877. DOI:10.1007/s12603-015-0509-9
  • Corlateanu A, Botnaru V, Covantev S, et al. Predicting health-related quality of life in patients with chronic obstructive pulmonary disease: the impact of age. Respiration. 2016;92(4):229–234. DOI:10.1159/000448625
  • Martelli A, Testai L, Colletti A, et al. Coenzyme Q(10): clinical applications in cardiovascular diseases. Antioxidants (Basel, Switzerland). 2020;9(4):341.
  • Skarlovnik A, Janić M, Lunder M, et al. Coenzyme Q10 supplementation decreases statin-related mild-to-moderate muscle symptoms: a randomized clinical study. Medical Science Monitor. 2014;20:2183–2188.
  • Díaz-Casado ME, Quiles JL, Barriocanal-Casado E, et al. The paradox of coenzyme Q(10) in aging. Nutrients. 2019;11(9):2221. DOI:10.3390/nu11092221

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.